LIFE — Lifecare ASA Share Price
- NOK221.49m
- NOK156.12m
- NOK13.09m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.61 | ||
Price to Tang. Book | 3.07 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 14.7 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -70.99% | ||
Return on Equity | -101.23% | ||
Operating Margin | -443.78% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | NOKm | 2.07 | 5.39 | 1.6 | 22.13 | 13.09 | 12 | 18 | 30.29% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- September 20th, 2006
- Public Since
- July 10th, 2018
- No. of Employees
- 32
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Oslo Stock Exchange
- Shares in Issue
- 14,915,149.29
- Address
- Ytrebygdsvegen 215, BERGEN, 5258
- Web
- https://lifecare.no/
- Phone
- Auditors
- RSM Norge AS
Upcoming Events for LIFE
Similar to LIFE
Arcticzymes Technologies ASA
Oslo Stock Exchange
Bergenbio ASA
Oslo Stock Exchange
Circio Holding ASA
Oslo Stock Exchange
Exact Therapeutics AS
Oslo Stock Exchange
Lytix Biopharma AS
Oslo Stock Exchange
FAQ
As of Today at 20:47 UTC, shares in Lifecare ASA are trading at NOK14.85. This share price information is delayed by 15 minutes.
Shares in Lifecare ASA last closed at NOK14.85 and the price had moved by -64.35% over the past 365 days. In terms of relative price strength the Lifecare ASA share price has underperformed the FTSE Global All Cap Index by -67.58% over the past year.
There is no consensus recommendation for this security.
Find out moreLifecare ASA does not currently pay a dividend.
Lifecare ASA does not currently pay a dividend.
Lifecare ASA does not currently pay a dividend.
To buy shares in Lifecare ASA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of NOK14.85, shares in Lifecare ASA had a market capitalisation of NOK221.49m.
Here are the trading details for Lifecare ASA:
- Country of listing: Norway
- Exchange: OSL
- Ticker Symbol: LIFE
Based on an overall assessment of its quality, value and momentum Lifecare ASA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Lifecare ASA is NOK36.00. That is 142.42% above the last closing price of NOK14.85.
Analysts covering Lifecare ASA currently have a consensus Earnings Per Share (EPS) forecast of -NOK4.68 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lifecare ASA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -45.82%.
As of the last closing price of NOK14.85, shares in Lifecare ASA were trading -44.61% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Lifecare ASA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at NOK14.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Lifecare ASA's directors